Applicability and generalisability of the results of systematic reviews to public health practice and policy: A systematic review

Trials

Volumn 11, Issue , 2010, Pages

  Ahmad, Nizar ^a,b,c   Boutron, Isabelle ^a,b,c   Dechartres, Agnès ^a,b,c   Durieux, Pierre ^c,d   Ravaud, Philippe ^a,b,c,d  

^a HÔTEL DIEU   (France)

^b INSERM   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

^d ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AGE DISTRIBUTION; ARTICLE; CLINICAL RESEARCH; COMORBIDITY; ETHNICITY; EXTERNAL VALIDITY; HEALTH CARE POLICY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION CONTROL; INTERVENTION STUDY; MEDLINE; OUTCOME ASSESSMENT; PATIENT IDENTIFICATION; PUBLIC HEALTH SERVICE; QUANTITATIVE ANALYSIS; SENSITIVITY ANALYSIS; SEX DIFFERENCE; SMOKING CESSATION; SOCIAL STATUS; SYSTEMATIC REVIEW; TREATMENT DURATION; ADOLESCENT; ADULT; CHILD; EVIDENCE BASED MEDICINE; FEMALE; HEALTH CARE PLANNING; HEALTH SERVICES RESEARCH; LEGAL ASPECT; LITERATURE; MALE; MIDDLE AGED; REPRODUCIBILITY; REVIEW; SMOKING; TREATMENT OUTCOME;

ADOLESCENT; ADULT; CHILD; EVIDENCE-BASED MEDICINE; FEMALE; HEALTH POLICY; HEALTH PRIORITIES; HEALTH SERVICES RESEARCH; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); PUBLIC HEALTH PRACTICE; REPRODUCIBILITY OF RESULTS; REVIEW LITERATURE AS TOPIC; SMOKING; SMOKING CESSATION; TREATMENT OUTCOME; YOUNG ADULT;

EID: 77949391715     PISSN: 17456215     EISSN: 17456215     Source Type: Journal    
DOI: 10.1186/1745-6215-11-20     Document Type: Article

References (45)

1. Silagy CA, Stead LF, Lancaster T. Use of systematic reviews in clinical practice guidelines: case study of smoking cessation. Bmj 2001, 323(7317):833-6. 10.1136/bmj.323.7317.833, 57801, 11597966.
2. Sackett DL, Rosenberg WM, Gray JA, Haynes RB, Richardson WS. Evidence based medicine: what it is and what it isn't. BMJ 1996, 312(7023):71-2. 2349778, 8555924.
3. Moher D, Tetzlaff J, Tricco AC, Sampson M, Altman DG. Epidemiology and reporting characteristics of systematic reviews. PLoS Med 2007, 4(3):e78. 10.1371/journal.pmed.0040078, 1831728, 17388659.
4. Dekkers OM, von Elm E, Algra A, Romijn JA, Vandenbroucke JP. How to assess the external validity of therapeutic trials: a conceptual approach. Int J Epidemiol 2009, 39(1):89-94. 10.1093/ije/dyp174, 19376882.
5. Berlin JA, Rennie D. Measuring the quality of trials: the quality of quality scales. JAMA 1999, 282(11):1083-5. 10.1001/jama.282.11.1083, 10493209.
6. Downs SH, Black N. The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions. J Epidemiol Community Health 1998, 52(6):377-84. 10.1136/jech.52.6.377, 1756728, 9764259.
7. Juni P, Altman DG, Egger M. Systematic reviews in health care: Assessing the quality of controlled clinical trials. Bmj 2001, 323(7303):42-6. 10.1136/bmj.323.7303.42, 1120670, 11440947.
8. Juni P, Witschi A, Bloch R, Egger M. The hazards of scoring the quality of clinical trials for meta-analysis. JAMA 1999, 282(11):1054-60. 10.1001/jama.282.11.1054, 10493204.
9. Moher D, Jadad AR, Nichol G, Penman M, Tugwell P, Walsh S. Assessing the quality of randomized controlled trials: an annotated bibliography of scales and checklists. Control Clin Trials 1995, 16(1):62-73. 10.1016/0197-2456(94)00031-W, 7743790.
10. Verhagen AP, de Vet HC, de Bie RA, Kessels AG, Boers M, Bouter LM, Knipschild PG. The Delphi list: a criteria list for quality assessment of randomized clinical trials for conducting systematic reviews developed by Delphi consensus. J Clin Epidemiol 1998, 51(12):1235-41. 10.1016/S0895-4356(98)00131-0, 10086815.
11. Lundh A, Gotzsche PC. Recommendations by Cochrane Review Groups for assessment of the risk of bias in studies. BMC Med Res Methodol 2008, 8(22):22. 10.1186/1471-2288-8-22, 2375895, 18426565.
12. Hartling L, Ospina M, Liang Y, Dryden DM, Hooton N, Krebs Seida J, Klassen TP. Risk of bias versus quality assessment of randomised controlled trials: cross sectional study. BMJ 2009, 339(339):b4012. 10.1136/bmj.b4012, 2764034, 19841007.
13. Straus SE, McAlister F. Applying the results of trials and systematic reviews to our individual patients. Evid Based Ment Health 2001, 4(1):6-7. 10.1136/ebmh.4.1.6, 11467072.
14. Hampton JR. Size isn't everything. Stat Med 2002, 21(19):2807-14. 10.1002/sim.1284, 12325096.
15. Naylor CD. Grey zones of clinical practice: some limits to evidence-based medicine. Lancet 1995, 345(8953):840-2. 10.1016/S0140-6736(95)92969-X, 7898234.
16. Rothwell PM. External validity of randomised controlled trials: "to whom do the results of this trial apply?". Lancet 2005, 365(9453):82-93. 10.1016/S0140-6736(04)17670-8, 15639683.
17. Pibouleau L, Boutron I, Reeves BC, Nizard R, Ravaud P. Applicability and generalisability of published results of randomised controlled trials and non-randomised studies evaluating four orthopaedic procedures: methodological systematic review. BMJ 2009, 339(339):b4538. 10.1136/bmj.b4538, 2778750, 19920015.
18. Ahmad N, Boutron I, Moher D, Pitrou I, Roy C, Ravaud P. Neglected external validity in reports of randomized trials: the example of hip and knee osteoarthritis. Arthritis Rheum 2009, 61(3):361-9. 10.1002/art.24279, 19248133.
19. Glasziou P, Meats E, Heneghan C, Shepperd S. What is missing from descriptions of treatment in trials and reviews?. BMJ 2008, 336(7659):1472-4. 10.1136/bmj.39590.732037.47, 18583680.
20. Jadad AR, Cook DJ, Jones A, Klassen TP, Tugwell P, Moher M, Moher D. Methodology and reports of systematic reviews and meta-analyses: a comparison of Cochrane reviews with articles published in paper-based journals. JAMA 1998, 280(3):278-80. 10.1001/jama.280.3.278, 9676681.
21. Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet 2006, 367(9524):1747-57. 10.1016/S0140-6736(06)68770-9, 16731270.
22. WHO WHO Report on the Global Tobacco Epidemic, 2008 - The MPOWER package. 2008, WHO, WHO.
23. Murray CJ, Lopez AD. Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet 1997, 349(9064):1498-504. 10.1016/S0140-6736(96)07492-2, 9167458.
24. Gilmore A, Pomerleau J, McKee M, Rose R, Haerpfer CW, Rotman D, Tumanov S. Prevalence of smoking in 8 countries of the former Soviet Union: results from the living conditions, lifestyles and health study. Am J Public Health 2004, 94(12):2177-87. 10.2105/AJPH.94.12.2177, 1448609, 15569971.
25. Wu Z, Sullivan SG, Wang Y, Rotheram-Borus MJ, Detels R. Evolution of China's response to HIV/AIDS. Lancet 2007, 369(9562):679-90. 10.1016/S0140-6736(07)60315-8, 17321313.
26. WHO WHO, World Health Statistics Report, 2008. 2008, WHO, WHO.
27. Patrick K, Scutchfield FD, Woolf SH. External validity reporting in prevention research. Am J Prev Med 2008, 34(3):260-2. 10.1016/j.amepre.2007.11.011, 18312815.
28. Klesges LM, Dzewaltowski DA, Glasgow RE. Review of external validity reporting in childhood obesity prevention research. Am J Prev Med 2008, 34(3):216-23. 10.1016/j.amepre.2007.11.019, 18312810.
29. Bonell C, Oakley A, Hargreaves J, Strange V, Rees R. Assessment of generalisability in trials of health interventions: suggested framework and systematic review. BMJ 2006, 333(7563):346-9. 10.1136/bmj.333.7563.346, 1539056, 16902217.
30. Higgins J, Green. Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.0 [updated February 2008]. 2008, The Cochrane Collaboration., http://www.cochrane-handbook.org
31. Altman DG, Schulz KF, Moher D, Egger M, Davidoff F, Elbourne D, Gøtzsche PC, Lang T, CONSORT GROUP (Consolidated Standards of Reporting Trials) The revised CONSORT statement for reporting randomized trials: explanation and elaboration. Ann Intern Med 2001, 134(8):663-94. CONSORT GROUP (Consolidated Standards of Reporting Trials).
32. Ethgen M, Boutron L, Steg PG, Roy C, Ravaud P. Quality of reporting internal and external validity data from randomized controlled trials evaluating stents for percutaneous coronary intervention. BMC Med Res Methodol 2009, 9:24. 10.1186/1471-2288-9-24, 2679061, 19358717.
33. Boutron I, Moher D, Altman DG, Schulz KF, Ravaud P, CONSORT Group Extending the CONSORT statement to randomized trials of nonpharmacologic treatment: explanation and elaboration. Ann Intern Med 2008, 148(4):295-309. CONSORT Group.
34. Giraudeau B, Mary JY. Planning a reproducibility study: how many subjects and how many replicates per subject for an expected width of the 95 per cent confidence interval of the intraclass correlation coefficient. Stat Med 2001, 20(21):3205-14. 10.1002/sim.935, 11746313.
35. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JP, Clarke M, Devereaux PJ, Kleijnen J, Moher D. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ 2009, 339:b2700. 10.1136/bmj.b2700, 2714672, 19622552.
36. White AR, Rampes H, Campbell JL. Acupuncture and related interventions for smoking cessation. Cochrane Database Syst Rev 2006, 25(1):CD000009.
37. Anczak JD, Nogler RA. Tobacco cessation in primary care: maximizing intervention strategies. Clin Med Res 2003, 1(3):201-16. 10.3121/cmr.1.3.201, 1069046, 15931310.
38. Biau DJ, Porcher R, Boutron I. The account for provider and center effects in multicenter interventional and surgical randomized controlled trials is in need of improvement: a review. J Clin Epidemiol 2008, 61(5):435-9. 10.1016/j.jclinepi.2007.10.018, 18394535.
39. Glasgow RE, Bull SS, Gillette C, Klesges LM, Dzewaltowski DA. Behavior change intervention research in healthcare settings: a review of recent reports with emphasis on external validity. Am J Prev Med 2002, 23(1):62-9. 10.1016/S0749-3797(02)00437-3, 12093425.
40. Jaeschke R, Guyatt GH, Dellinger P, Schünemann H, Levy MM, Kunz R, Norris S, Bion J, GRADE Working Group Use of GRADE grid to reach decisions on clinical practice guidelines when consensus is elusive. BMJ 2008, 337:a744. 10.1136/bmj.a744, 18669566, GRADE Working Group.
41. Atkins D, Best D, Briss PA, Eccles M, Falck-Ytter Y, Flottorp S, Guyatt GH, Harbour RT, Haugh MC, Henry D, Hill S, Jaeschke R, Leng G, Liberati A, Magrini N, Mason J, Middleton P, Mrukowicz J, O'Connell D, Oxman AD, Phillips B, Schünemann HJ, Edejer TT, Varonen H, Vist GE, Williams JW, Zaza S, GRADE Working Group Grading quality of evidence and strength of recommendations. BMJ 2004, 328(7454):1490. 10.1136/bmj.328.7454.1490, 428525, 15205295, GRADE Working Group.
42. McAlister FA, van Diepen S, Padwal RS, Johnson JA, Majumdar SR. How evidence-based are the recommendations in evidence-based guidelines?. PLoS Med 2007, 4(8):e250. 10.1371/journal.pmed.0040250, 1939859,1939859, 17683197.
43. Moja LP, Telaro E, D'Amico R, Moschetti I, Coe L, Liberati A. Assessment of methodological quality of primary studies by systematic reviews: results of the metaquality cross sectional study. BMJ 2005, 330(7499):1053. 10.1136/bmj.38414.515938.8F, 557223, 15817526.
44. Moher D, Cook DJ, Jadad AR, Tugwell P, Moher M, Jones A, Pham B, Klassen TP. Assessing the quality of reports of randomised trials: implications for the conduct of meta-analyses. Health Technol Assess 1999, 3(12):i-iv. 1-98.
45. Merson MH, O'Malley J, Serwadda D, Apisuk C. The history and challenge of HIV prevention. Lancet 2008, 372(9637):475-88. 10.1016/S0140-6736(08)60884-3, 18687461.